Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus

NCT04027023 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Diabetes mellitus Type 2 De-escalation treatment (DET)

Sponsor

Sciema UG

Collaborators

[object Object]